nodes	percent_of_prediction	percent_of_DWPC	metapath
Almotriptan—migraine—Prednisone—multiple sclerosis	0.535	1	CpDpCtD
Almotriptan—CYP2E1—Fingolimod—multiple sclerosis	0.0662	0.243	CbGbCtD
Almotriptan—CYP2D6—Fingolimod—multiple sclerosis	0.0316	0.116	CbGbCtD
Almotriptan—CYP2E1—Mitoxantrone—multiple sclerosis	0.0311	0.114	CbGbCtD
Almotriptan—CYP3A4—Fingolimod—multiple sclerosis	0.0201	0.0736	CbGbCtD
Almotriptan—HTR1B—trigeminal nucleus—multiple sclerosis	0.0192	0.256	CbGeAlD
Almotriptan—HTR1D—trigeminal nucleus—multiple sclerosis	0.0186	0.248	CbGeAlD
Almotriptan—CYP2C19—Prednisone—multiple sclerosis	0.0162	0.0594	CbGbCtD
Almotriptan—CYP2E1—Dexamethasone—multiple sclerosis	0.0161	0.0592	CbGbCtD
Almotriptan—CYP3A4—Methylprednisolone—multiple sclerosis	0.0129	0.0474	CbGbCtD
Almotriptan—HTR1D—meninx—multiple sclerosis	0.0124	0.165	CbGeAlD
Almotriptan—CYP2C8—Dexamethasone—multiple sclerosis	0.0121	0.0442	CbGbCtD
Almotriptan—CYP2C19—Dexamethasone—multiple sclerosis	0.0101	0.0371	CbGbCtD
Almotriptan—CYP3A4—Triamcinolone—multiple sclerosis	0.0098	0.0359	CbGbCtD
Almotriptan—CYP3A4—Mitoxantrone—multiple sclerosis	0.00943	0.0346	CbGbCtD
Almotriptan—CYP3A4—Betamethasone—multiple sclerosis	0.00841	0.0308	CbGbCtD
Almotriptan—CYP3A4—Prednisolone—multiple sclerosis	0.0083	0.0304	CbGbCtD
Almotriptan—CYP3A4—Prednisone—multiple sclerosis	0.00783	0.0287	CbGbCtD
Almotriptan—CYP2D6—Dexamethasone—multiple sclerosis	0.00769	0.0282	CbGbCtD
Almotriptan—HTR1B—trigeminal nerve—multiple sclerosis	0.00505	0.0672	CbGeAlD
Almotriptan—CYP3A4—Dexamethasone—multiple sclerosis	0.00489	0.0179	CbGbCtD
Almotriptan—HTR1D—trigeminal nerve—multiple sclerosis	0.00489	0.0651	CbGeAlD
Almotriptan—MAOA—nerve—multiple sclerosis	0.00136	0.0181	CbGeAlD
Almotriptan—HTR1B—brainstem—multiple sclerosis	0.000791	0.0105	CbGeAlD
Almotriptan—HTR1D—brainstem—multiple sclerosis	0.000766	0.0102	CbGeAlD
Almotriptan—FMO3—nervous system—multiple sclerosis	0.000707	0.00941	CbGeAlD
Almotriptan—FMO3—central nervous system—multiple sclerosis	0.00068	0.00906	CbGeAlD
Almotriptan—MAOA—brainstem—multiple sclerosis	0.000583	0.00777	CbGeAlD
Almotriptan—MAOA—retina—multiple sclerosis	0.000563	0.0075	CbGeAlD
Almotriptan—FMO3—brain—multiple sclerosis	0.00054	0.00719	CbGeAlD
Almotriptan—HTR1B—midbrain—multiple sclerosis	0.000504	0.00672	CbGeAlD
Almotriptan—HTR1B—spinal cord—multiple sclerosis	0.000492	0.00655	CbGeAlD
Almotriptan—HTR1D—midbrain—multiple sclerosis	0.000488	0.0065	CbGeAlD
Almotriptan—HTR1B—nervous system—multiple sclerosis	0.000415	0.00552	CbGeAlD
Almotriptan—MAOA—medulla oblongata—multiple sclerosis	0.000407	0.00542	CbGeAlD
Almotriptan—HTR1D—nervous system—multiple sclerosis	0.000401	0.00535	CbGeAlD
Almotriptan—HTR1B—central nervous system—multiple sclerosis	0.000399	0.00532	CbGeAlD
Almotriptan—HTR1D—central nervous system—multiple sclerosis	0.000386	0.00515	CbGeAlD
Almotriptan—MAOA—midbrain—multiple sclerosis	0.000372	0.00495	CbGeAlD
Almotriptan—MAOA—spinal cord—multiple sclerosis	0.000363	0.00483	CbGeAlD
Almotriptan—CYP2D6—brainstem—multiple sclerosis	0.000347	0.00462	CbGeAlD
Almotriptan—HTR1B—brain—multiple sclerosis	0.000317	0.00422	CbGeAlD
Almotriptan—HTR1D—brain—multiple sclerosis	0.000307	0.00409	CbGeAlD
Almotriptan—MAOA—nervous system—multiple sclerosis	0.000306	0.00407	CbGeAlD
Almotriptan—CYP2E1—medulla oblongata—multiple sclerosis	0.000305	0.00407	CbGeAlD
Almotriptan—MAOA—central nervous system—multiple sclerosis	0.000294	0.00392	CbGeAlD
Almotriptan—MAOA—cerebellum—multiple sclerosis	0.000288	0.00383	CbGeAlD
Almotriptan—CYP2E1—spinal cord—multiple sclerosis	0.000272	0.00363	CbGeAlD
Almotriptan—MAOA—brain—multiple sclerosis	0.000234	0.00311	CbGeAlD
Almotriptan—CYP2E1—nervous system—multiple sclerosis	0.000229	0.00306	CbGeAlD
Almotriptan—CYP2E1—central nervous system—multiple sclerosis	0.000221	0.00294	CbGeAlD
Almotriptan—CYP2E1—cerebellum—multiple sclerosis	0.000216	0.00288	CbGeAlD
Almotriptan—CYP2C8—brain—multiple sclerosis	0.000208	0.00277	CbGeAlD
Almotriptan—CYP3A4—nervous system—multiple sclerosis	0.000185	0.00246	CbGeAlD
Almotriptan—CYP2D6—nervous system—multiple sclerosis	0.000182	0.00242	CbGeAlD
Almotriptan—CYP3A4—central nervous system—multiple sclerosis	0.000178	0.00237	CbGeAlD
Almotriptan—CYP2E1—brain—multiple sclerosis	0.000175	0.00234	CbGeAlD
Almotriptan—CYP2D6—central nervous system—multiple sclerosis	0.000175	0.00233	CbGeAlD
Almotriptan—CYP2D6—cerebellum—multiple sclerosis	0.000171	0.00228	CbGeAlD
Almotriptan—CYP2D6—brain—multiple sclerosis	0.000139	0.00185	CbGeAlD
Almotriptan—Hypertension—Triamcinolone—multiple sclerosis	0.000126	0.00149	CcSEcCtD
Almotriptan—Hypertension—Methylprednisolone—multiple sclerosis	0.000126	0.00148	CcSEcCtD
Almotriptan—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000126	0.00148	CcSEcCtD
Almotriptan—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000125	0.00147	CcSEcCtD
Almotriptan—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000125	0.00147	CcSEcCtD
Almotriptan—Myalgia—Triamcinolone—multiple sclerosis	0.000125	0.00146	CcSEcCtD
Almotriptan—Vomiting—Azathioprine—multiple sclerosis	0.000125	0.00146	CcSEcCtD
Almotriptan—Arthralgia—Methylprednisolone—multiple sclerosis	0.000124	0.00146	CcSEcCtD
Almotriptan—Myalgia—Methylprednisolone—multiple sclerosis	0.000124	0.00146	CcSEcCtD
Almotriptan—Eye disorder—Prednisone—multiple sclerosis	0.000124	0.00146	CcSEcCtD
Almotriptan—Anxiety—Methylprednisolone—multiple sclerosis	0.000124	0.00146	CcSEcCtD
Almotriptan—Rash—Azathioprine—multiple sclerosis	0.000124	0.00145	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000124	0.00145	CcSEcCtD
Almotriptan—Dermatitis—Azathioprine—multiple sclerosis	0.000123	0.00145	CcSEcCtD
Almotriptan—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000123	0.00145	CcSEcCtD
Almotriptan—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000123	0.00145	CcSEcCtD
Almotriptan—Discomfort—Triamcinolone—multiple sclerosis	0.000123	0.00145	CcSEcCtD
Almotriptan—Discomfort—Methylprednisolone—multiple sclerosis	0.000123	0.00144	CcSEcCtD
Almotriptan—Headache—Azathioprine—multiple sclerosis	0.000123	0.00144	CcSEcCtD
Almotriptan—Dry mouth—Triamcinolone—multiple sclerosis	0.000122	0.00143	CcSEcCtD
Almotriptan—Angioedema—Betamethasone—multiple sclerosis	0.000121	0.00143	CcSEcCtD
Almotriptan—Angioedema—Dexamethasone—multiple sclerosis	0.000121	0.00143	CcSEcCtD
Almotriptan—Conjunctivitis—Methotrexate—multiple sclerosis	0.00012	0.00141	CcSEcCtD
Almotriptan—Confusional state—Methylprednisolone—multiple sclerosis	0.00012	0.00141	CcSEcCtD
Almotriptan—Immune system disorder—Prednisone—multiple sclerosis	0.00012	0.00141	CcSEcCtD
Almotriptan—Malaise—Dexamethasone—multiple sclerosis	0.00012	0.00141	CcSEcCtD
Almotriptan—Malaise—Betamethasone—multiple sclerosis	0.00012	0.00141	CcSEcCtD
Almotriptan—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.00012	0.0014	CcSEcCtD
Almotriptan—Vertigo—Dexamethasone—multiple sclerosis	0.000119	0.0014	CcSEcCtD
Almotriptan—Vertigo—Betamethasone—multiple sclerosis	0.000119	0.0014	CcSEcCtD
Almotriptan—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000119	0.0014	CcSEcCtD
Almotriptan—Syncope—Dexamethasone—multiple sclerosis	0.000119	0.0014	CcSEcCtD
Almotriptan—Syncope—Betamethasone—multiple sclerosis	0.000119	0.0014	CcSEcCtD
Almotriptan—Shock—Triamcinolone—multiple sclerosis	0.000118	0.00138	CcSEcCtD
Almotriptan—Insomnia—Prednisolone—multiple sclerosis	0.000118	0.00138	CcSEcCtD
Almotriptan—Shock—Methylprednisolone—multiple sclerosis	0.000117	0.00138	CcSEcCtD
Almotriptan—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000117	0.00137	CcSEcCtD
Almotriptan—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000117	0.00137	CcSEcCtD
Almotriptan—Loss of consciousness—Betamethasone—multiple sclerosis	0.000117	0.00137	CcSEcCtD
Almotriptan—Epistaxis—Methotrexate—multiple sclerosis	0.000117	0.00137	CcSEcCtD
Almotriptan—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000117	0.00137	CcSEcCtD
Almotriptan—Paraesthesia—Prednisolone—multiple sclerosis	0.000117	0.00137	CcSEcCtD
Almotriptan—Tachycardia—Triamcinolone—multiple sclerosis	0.000117	0.00137	CcSEcCtD
Almotriptan—Mental disorder—Prednisone—multiple sclerosis	0.000116	0.00137	CcSEcCtD
Almotriptan—Nausea—Azathioprine—multiple sclerosis	0.000116	0.00137	CcSEcCtD
Almotriptan—Tachycardia—Methylprednisolone—multiple sclerosis	0.000116	0.00137	CcSEcCtD
Almotriptan—Skin disorder—Methylprednisolone—multiple sclerosis	0.000116	0.00136	CcSEcCtD
Almotriptan—Erythema—Prednisone—multiple sclerosis	0.000116	0.00136	CcSEcCtD
Almotriptan—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000116	0.00136	CcSEcCtD
Almotriptan—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000115	0.00135	CcSEcCtD
Almotriptan—Convulsion—Betamethasone—multiple sclerosis	0.000115	0.00135	CcSEcCtD
Almotriptan—Convulsion—Dexamethasone—multiple sclerosis	0.000115	0.00135	CcSEcCtD
Almotriptan—Hypertension—Dexamethasone—multiple sclerosis	0.000115	0.00135	CcSEcCtD
Almotriptan—Hypertension—Betamethasone—multiple sclerosis	0.000115	0.00135	CcSEcCtD
Almotriptan—Asthenia—Mitoxantrone—multiple sclerosis	0.000114	0.00133	CcSEcCtD
Almotriptan—Myalgia—Betamethasone—multiple sclerosis	0.000113	0.00133	CcSEcCtD
Almotriptan—Myalgia—Dexamethasone—multiple sclerosis	0.000113	0.00133	CcSEcCtD
Almotriptan—Anxiety—Dexamethasone—multiple sclerosis	0.000113	0.00132	CcSEcCtD
Almotriptan—Anxiety—Betamethasone—multiple sclerosis	0.000113	0.00132	CcSEcCtD
Almotriptan—Discomfort—Dexamethasone—multiple sclerosis	0.000112	0.00131	CcSEcCtD
Almotriptan—Discomfort—Betamethasone—multiple sclerosis	0.000112	0.00131	CcSEcCtD
Almotriptan—Pain—Prednisolone—multiple sclerosis	0.000111	0.00131	CcSEcCtD
Almotriptan—Pharyngitis—Methotrexate—multiple sclerosis	0.00011	0.0013	CcSEcCtD
Almotriptan—Vision blurred—Prednisone—multiple sclerosis	0.000109	0.00128	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000109	0.00128	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000109	0.00128	CcSEcCtD
Almotriptan—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000108	0.00127	CcSEcCtD
Almotriptan—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000108	0.00127	CcSEcCtD
Almotriptan—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000108	0.00127	CcSEcCtD
Almotriptan—Insomnia—Triamcinolone—multiple sclerosis	0.000108	0.00127	CcSEcCtD
Almotriptan—Insomnia—Methylprednisolone—multiple sclerosis	0.000108	0.00127	CcSEcCtD
Almotriptan—Ill-defined disorder—Prednisone—multiple sclerosis	0.000107	0.00126	CcSEcCtD
Almotriptan—Paraesthesia—Triamcinolone—multiple sclerosis	0.000107	0.00126	CcSEcCtD
Almotriptan—Feeling abnormal—Prednisolone—multiple sclerosis	0.000107	0.00126	CcSEcCtD
Almotriptan—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000107	0.00126	CcSEcCtD
Almotriptan—Visual impairment—Methotrexate—multiple sclerosis	0.000107	0.00126	CcSEcCtD
Almotriptan—Shock—Dexamethasone—multiple sclerosis	0.000107	0.00125	CcSEcCtD
Almotriptan—Shock—Betamethasone—multiple sclerosis	0.000107	0.00125	CcSEcCtD
Almotriptan—Dyspnoea—Triamcinolone—multiple sclerosis	0.000107	0.00125	CcSEcCtD
Almotriptan—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000106	0.00125	CcSEcCtD
Almotriptan—Nervous system disorder—Betamethasone—multiple sclerosis	0.000106	0.00125	CcSEcCtD
Almotriptan—Agitation—Prednisone—multiple sclerosis	0.000106	0.00125	CcSEcCtD
Almotriptan—Tachycardia—Dexamethasone—multiple sclerosis	0.000106	0.00124	CcSEcCtD
Almotriptan—Tachycardia—Betamethasone—multiple sclerosis	0.000106	0.00124	CcSEcCtD
Almotriptan—Angioedema—Prednisone—multiple sclerosis	0.000106	0.00124	CcSEcCtD
Almotriptan—Dyspepsia—Triamcinolone—multiple sclerosis	0.000105	0.00124	CcSEcCtD
Almotriptan—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000105	0.00123	CcSEcCtD
Almotriptan—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000105	0.00123	CcSEcCtD
Almotriptan—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000105	0.00123	CcSEcCtD
Almotriptan—Malaise—Prednisone—multiple sclerosis	0.000104	0.00123	CcSEcCtD
Almotriptan—Vertigo—Prednisone—multiple sclerosis	0.000104	0.00122	CcSEcCtD
Almotriptan—Eye disorder—Methotrexate—multiple sclerosis	0.000104	0.00122	CcSEcCtD
Almotriptan—Syncope—Prednisone—multiple sclerosis	0.000104	0.00122	CcSEcCtD
Almotriptan—Tinnitus—Methotrexate—multiple sclerosis	0.000104	0.00122	CcSEcCtD
Almotriptan—Cardiac disorder—Methotrexate—multiple sclerosis	0.000103	0.00121	CcSEcCtD
Almotriptan—Fatigue—Triamcinolone—multiple sclerosis	0.000103	0.00121	CcSEcCtD
Almotriptan—Fatigue—Methylprednisolone—multiple sclerosis	0.000103	0.00121	CcSEcCtD
Almotriptan—Pain—Triamcinolone—multiple sclerosis	0.000102	0.0012	CcSEcCtD
Almotriptan—Loss of consciousness—Prednisone—multiple sclerosis	0.000102	0.00119	CcSEcCtD
Almotriptan—Vomiting—Mitoxantrone—multiple sclerosis	0.000101	0.00118	CcSEcCtD
Almotriptan—Immune system disorder—Methotrexate—multiple sclerosis	0.0001	0.00118	CcSEcCtD
Almotriptan—Convulsion—Prednisone—multiple sclerosis	0.0001	0.00118	CcSEcCtD
Almotriptan—Hypertension—Prednisone—multiple sclerosis	9.99e-05	0.00117	CcSEcCtD
Almotriptan—Rash—Mitoxantrone—multiple sclerosis	9.99e-05	0.00117	CcSEcCtD
Almotriptan—Dermatitis—Mitoxantrone—multiple sclerosis	9.98e-05	0.00117	CcSEcCtD
Almotriptan—Chills—Methotrexate—multiple sclerosis	9.97e-05	0.00117	CcSEcCtD
Almotriptan—Headache—Mitoxantrone—multiple sclerosis	9.93e-05	0.00117	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	9.88e-05	0.00116	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	9.88e-05	0.00116	CcSEcCtD
Almotriptan—Arthralgia—Prednisone—multiple sclerosis	9.85e-05	0.00116	CcSEcCtD
Almotriptan—Myalgia—Prednisone—multiple sclerosis	9.85e-05	0.00116	CcSEcCtD
Almotriptan—Feeling abnormal—Triamcinolone—multiple sclerosis	9.85e-05	0.00116	CcSEcCtD
Almotriptan—Feeling abnormal—Methylprednisolone—multiple sclerosis	9.83e-05	0.00115	CcSEcCtD
Almotriptan—Anxiety—Prednisone—multiple sclerosis	9.82e-05	0.00115	CcSEcCtD
Almotriptan—Insomnia—Betamethasone—multiple sclerosis	9.81e-05	0.00115	CcSEcCtD
Almotriptan—Insomnia—Dexamethasone—multiple sclerosis	9.81e-05	0.00115	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	9.78e-05	0.00115	CcSEcCtD
Almotriptan—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	9.75e-05	0.00115	CcSEcCtD
Almotriptan—Paraesthesia—Dexamethasone—multiple sclerosis	9.74e-05	0.00114	CcSEcCtD
Almotriptan—Paraesthesia—Betamethasone—multiple sclerosis	9.74e-05	0.00114	CcSEcCtD
Almotriptan—Discomfort—Prednisone—multiple sclerosis	9.73e-05	0.00114	CcSEcCtD
Almotriptan—Mental disorder—Methotrexate—multiple sclerosis	9.73e-05	0.00114	CcSEcCtD
Almotriptan—Erythema—Methotrexate—multiple sclerosis	9.67e-05	0.00114	CcSEcCtD
Almotriptan—Hypersensitivity—Prednisolone—multiple sclerosis	9.58e-05	0.00112	CcSEcCtD
Almotriptan—Dyspepsia—Betamethasone—multiple sclerosis	9.55e-05	0.00112	CcSEcCtD
Almotriptan—Dyspepsia—Dexamethasone—multiple sclerosis	9.55e-05	0.00112	CcSEcCtD
Almotriptan—Dysgeusia—Methotrexate—multiple sclerosis	9.47e-05	0.00111	CcSEcCtD
Almotriptan—Body temperature increased—Triamcinolone—multiple sclerosis	9.45e-05	0.00111	CcSEcCtD
Almotriptan—Anaphylactic shock—Prednisone—multiple sclerosis	9.45e-05	0.00111	CcSEcCtD
Almotriptan—Abdominal pain—Methylprednisolone—multiple sclerosis	9.43e-05	0.00111	CcSEcCtD
Almotriptan—Nausea—Mitoxantrone—multiple sclerosis	9.41e-05	0.00111	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Betamethasone—multiple sclerosis	9.36e-05	0.0011	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	9.36e-05	0.0011	CcSEcCtD
Almotriptan—Back pain—Methotrexate—multiple sclerosis	9.36e-05	0.0011	CcSEcCtD
Almotriptan—Fatigue—Dexamethasone—multiple sclerosis	9.35e-05	0.0011	CcSEcCtD
Almotriptan—Fatigue—Betamethasone—multiple sclerosis	9.35e-05	0.0011	CcSEcCtD
Almotriptan—Shock—Prednisone—multiple sclerosis	9.29e-05	0.00109	CcSEcCtD
Almotriptan—Pain—Betamethasone—multiple sclerosis	9.27e-05	0.00109	CcSEcCtD
Almotriptan—Pain—Dexamethasone—multiple sclerosis	9.27e-05	0.00109	CcSEcCtD
Almotriptan—Nervous system disorder—Prednisone—multiple sclerosis	9.26e-05	0.00109	CcSEcCtD
Almotriptan—Tachycardia—Prednisone—multiple sclerosis	9.22e-05	0.00108	CcSEcCtD
Almotriptan—Skin disorder—Prednisone—multiple sclerosis	9.17e-05	0.00108	CcSEcCtD
Almotriptan—Hyperhidrosis—Prednisone—multiple sclerosis	9.13e-05	0.00107	CcSEcCtD
Almotriptan—Vision blurred—Methotrexate—multiple sclerosis	9.12e-05	0.00107	CcSEcCtD
Almotriptan—Ill-defined disorder—Methotrexate—multiple sclerosis	8.97e-05	0.00105	CcSEcCtD
Almotriptan—Feeling abnormal—Dexamethasone—multiple sclerosis	8.94e-05	0.00105	CcSEcCtD
Almotriptan—Feeling abnormal—Betamethasone—multiple sclerosis	8.94e-05	0.00105	CcSEcCtD
Almotriptan—Gastrointestinal pain—Betamethasone—multiple sclerosis	8.87e-05	0.00104	CcSEcCtD
Almotriptan—Gastrointestinal pain—Dexamethasone—multiple sclerosis	8.87e-05	0.00104	CcSEcCtD
Almotriptan—Hypersensitivity—Triamcinolone—multiple sclerosis	8.81e-05	0.00103	CcSEcCtD
Almotriptan—Hypersensitivity—Methylprednisolone—multiple sclerosis	8.79e-05	0.00103	CcSEcCtD
Almotriptan—Malaise—Methotrexate—multiple sclerosis	8.72e-05	0.00102	CcSEcCtD
Almotriptan—Vertigo—Methotrexate—multiple sclerosis	8.69e-05	0.00102	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Prednisone—multiple sclerosis	8.61e-05	0.00101	CcSEcCtD
Almotriptan—Dizziness—Prednisolone—multiple sclerosis	8.6e-05	0.00101	CcSEcCtD
Almotriptan—Asthenia—Triamcinolone—multiple sclerosis	8.58e-05	0.00101	CcSEcCtD
Almotriptan—Body temperature increased—Dexamethasone—multiple sclerosis	8.57e-05	0.00101	CcSEcCtD
Almotriptan—Body temperature increased—Betamethasone—multiple sclerosis	8.57e-05	0.00101	CcSEcCtD
Almotriptan—Abdominal pain—Betamethasone—multiple sclerosis	8.57e-05	0.00101	CcSEcCtD
Almotriptan—Abdominal pain—Dexamethasone—multiple sclerosis	8.57e-05	0.00101	CcSEcCtD
Almotriptan—Asthenia—Methylprednisolone—multiple sclerosis	8.56e-05	0.001	CcSEcCtD
Almotriptan—Insomnia—Prednisone—multiple sclerosis	8.54e-05	0.001	CcSEcCtD
Almotriptan—Paraesthesia—Prednisone—multiple sclerosis	8.48e-05	0.000996	CcSEcCtD
Almotriptan—Pruritus—Triamcinolone—multiple sclerosis	8.46e-05	0.000993	CcSEcCtD
Almotriptan—Pruritus—Methylprednisolone—multiple sclerosis	8.44e-05	0.000991	CcSEcCtD
Almotriptan—Convulsion—Methotrexate—multiple sclerosis	8.38e-05	0.000984	CcSEcCtD
Almotriptan—Dyspepsia—Prednisone—multiple sclerosis	8.31e-05	0.000976	CcSEcCtD
Almotriptan—Arthralgia—Methotrexate—multiple sclerosis	8.23e-05	0.000967	CcSEcCtD
Almotriptan—Chest pain—Methotrexate—multiple sclerosis	8.23e-05	0.000967	CcSEcCtD
Almotriptan—Myalgia—Methotrexate—multiple sclerosis	8.23e-05	0.000967	CcSEcCtD
Almotriptan—Rash—Prednisolone—multiple sclerosis	8.2e-05	0.000962	CcSEcCtD
Almotriptan—Dermatitis—Prednisolone—multiple sclerosis	8.19e-05	0.000962	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	8.18e-05	0.00096	CcSEcCtD
Almotriptan—Diarrhoea—Methylprednisolone—multiple sclerosis	8.16e-05	0.000958	CcSEcCtD
Almotriptan—Fatigue—Prednisone—multiple sclerosis	8.14e-05	0.000956	CcSEcCtD
Almotriptan—Headache—Prednisolone—multiple sclerosis	8.14e-05	0.000956	CcSEcCtD
Almotriptan—Discomfort—Methotrexate—multiple sclerosis	8.14e-05	0.000955	CcSEcCtD
Almotriptan—Confusional state—Methotrexate—multiple sclerosis	7.96e-05	0.000935	CcSEcCtD
Almotriptan—Dizziness—Triamcinolone—multiple sclerosis	7.9e-05	0.000928	CcSEcCtD
Almotriptan—Anaphylactic shock—Methotrexate—multiple sclerosis	7.89e-05	0.000927	CcSEcCtD
Almotriptan—Dizziness—Methylprednisolone—multiple sclerosis	7.89e-05	0.000926	CcSEcCtD
Almotriptan—Feeling abnormal—Prednisone—multiple sclerosis	7.78e-05	0.000914	CcSEcCtD
Almotriptan—Asthenia—Dexamethasone—multiple sclerosis	7.78e-05	0.000914	CcSEcCtD
Almotriptan—Asthenia—Betamethasone—multiple sclerosis	7.78e-05	0.000914	CcSEcCtD
Almotriptan—Nervous system disorder—Methotrexate—multiple sclerosis	7.74e-05	0.000909	CcSEcCtD
Almotriptan—Gastrointestinal pain—Prednisone—multiple sclerosis	7.72e-05	0.000907	CcSEcCtD
Almotriptan—Nausea—Prednisolone—multiple sclerosis	7.72e-05	0.000907	CcSEcCtD
Almotriptan—Pruritus—Dexamethasone—multiple sclerosis	7.67e-05	0.000901	CcSEcCtD
Almotriptan—Pruritus—Betamethasone—multiple sclerosis	7.67e-05	0.000901	CcSEcCtD
Almotriptan—Skin disorder—Methotrexate—multiple sclerosis	7.67e-05	0.0009	CcSEcCtD
Almotriptan—Hyperhidrosis—Methotrexate—multiple sclerosis	7.63e-05	0.000896	CcSEcCtD
Almotriptan—Vomiting—Triamcinolone—multiple sclerosis	7.6e-05	0.000893	CcSEcCtD
Almotriptan—Vomiting—Methylprednisolone—multiple sclerosis	7.58e-05	0.000891	CcSEcCtD
Almotriptan—Rash—Triamcinolone—multiple sclerosis	7.54e-05	0.000885	CcSEcCtD
Almotriptan—Dermatitis—Triamcinolone—multiple sclerosis	7.53e-05	0.000884	CcSEcCtD
Almotriptan—Rash—Methylprednisolone—multiple sclerosis	7.52e-05	0.000883	CcSEcCtD
Almotriptan—Dermatitis—Methylprednisolone—multiple sclerosis	7.51e-05	0.000882	CcSEcCtD
Almotriptan—Headache—Triamcinolone—multiple sclerosis	7.49e-05	0.000879	CcSEcCtD
Almotriptan—Headache—Methylprednisolone—multiple sclerosis	7.47e-05	0.000877	CcSEcCtD
Almotriptan—Abdominal pain—Prednisone—multiple sclerosis	7.47e-05	0.000877	CcSEcCtD
Almotriptan—Body temperature increased—Prednisone—multiple sclerosis	7.47e-05	0.000877	CcSEcCtD
Almotriptan—Diarrhoea—Betamethasone—multiple sclerosis	7.42e-05	0.000871	CcSEcCtD
Almotriptan—Diarrhoea—Dexamethasone—multiple sclerosis	7.42e-05	0.000871	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	7.19e-05	0.000845	CcSEcCtD
Almotriptan—Dizziness—Betamethasone—multiple sclerosis	7.17e-05	0.000842	CcSEcCtD
Almotriptan—Dizziness—Dexamethasone—multiple sclerosis	7.17e-05	0.000842	CcSEcCtD
Almotriptan—Insomnia—Methotrexate—multiple sclerosis	7.14e-05	0.000838	CcSEcCtD
Almotriptan—Nausea—Triamcinolone—multiple sclerosis	7.1e-05	0.000834	CcSEcCtD
Almotriptan—Paraesthesia—Methotrexate—multiple sclerosis	7.09e-05	0.000832	CcSEcCtD
Almotriptan—Nausea—Methylprednisolone—multiple sclerosis	7.08e-05	0.000832	CcSEcCtD
Almotriptan—Dyspnoea—Methotrexate—multiple sclerosis	7.04e-05	0.000826	CcSEcCtD
Almotriptan—Somnolence—Methotrexate—multiple sclerosis	7.02e-05	0.000824	CcSEcCtD
Almotriptan—Hypersensitivity—Prednisone—multiple sclerosis	6.96e-05	0.000817	CcSEcCtD
Almotriptan—Dyspepsia—Methotrexate—multiple sclerosis	6.95e-05	0.000816	CcSEcCtD
Almotriptan—Vomiting—Dexamethasone—multiple sclerosis	6.9e-05	0.00081	CcSEcCtD
Almotriptan—Vomiting—Betamethasone—multiple sclerosis	6.9e-05	0.00081	CcSEcCtD
Almotriptan—Rash—Betamethasone—multiple sclerosis	6.84e-05	0.000803	CcSEcCtD
Almotriptan—Rash—Dexamethasone—multiple sclerosis	6.84e-05	0.000803	CcSEcCtD
Almotriptan—Dermatitis—Betamethasone—multiple sclerosis	6.83e-05	0.000802	CcSEcCtD
Almotriptan—Dermatitis—Dexamethasone—multiple sclerosis	6.83e-05	0.000802	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Methotrexate—multiple sclerosis	6.81e-05	0.0008	CcSEcCtD
Almotriptan—Fatigue—Methotrexate—multiple sclerosis	6.81e-05	0.000799	CcSEcCtD
Almotriptan—Headache—Dexamethasone—multiple sclerosis	6.79e-05	0.000798	CcSEcCtD
Almotriptan—Headache—Betamethasone—multiple sclerosis	6.79e-05	0.000798	CcSEcCtD
Almotriptan—Asthenia—Prednisone—multiple sclerosis	6.78e-05	0.000796	CcSEcCtD
Almotriptan—Pain—Methotrexate—multiple sclerosis	6.75e-05	0.000793	CcSEcCtD
Almotriptan—Pruritus—Prednisone—multiple sclerosis	6.68e-05	0.000785	CcSEcCtD
Almotriptan—Feeling abnormal—Methotrexate—multiple sclerosis	6.5e-05	0.000764	CcSEcCtD
Almotriptan—Diarrhoea—Prednisone—multiple sclerosis	6.46e-05	0.000759	CcSEcCtD
Almotriptan—Gastrointestinal pain—Methotrexate—multiple sclerosis	6.45e-05	0.000758	CcSEcCtD
Almotriptan—Nausea—Dexamethasone—multiple sclerosis	6.44e-05	0.000757	CcSEcCtD
Almotriptan—Nausea—Betamethasone—multiple sclerosis	6.44e-05	0.000757	CcSEcCtD
Almotriptan—Dizziness—Prednisone—multiple sclerosis	6.25e-05	0.000734	CcSEcCtD
Almotriptan—Abdominal pain—Methotrexate—multiple sclerosis	6.24e-05	0.000733	CcSEcCtD
Almotriptan—Body temperature increased—Methotrexate—multiple sclerosis	6.24e-05	0.000733	CcSEcCtD
Almotriptan—Vomiting—Prednisone—multiple sclerosis	6.01e-05	0.000705	CcSEcCtD
Almotriptan—Rash—Prednisone—multiple sclerosis	5.96e-05	0.000699	CcSEcCtD
Almotriptan—Dermatitis—Prednisone—multiple sclerosis	5.95e-05	0.000699	CcSEcCtD
Almotriptan—Headache—Prednisone—multiple sclerosis	5.92e-05	0.000695	CcSEcCtD
Almotriptan—Hypersensitivity—Methotrexate—multiple sclerosis	5.82e-05	0.000683	CcSEcCtD
Almotriptan—Asthenia—Methotrexate—multiple sclerosis	5.66e-05	0.000665	CcSEcCtD
Almotriptan—Nausea—Prednisone—multiple sclerosis	5.61e-05	0.000659	CcSEcCtD
Almotriptan—Pruritus—Methotrexate—multiple sclerosis	5.58e-05	0.000656	CcSEcCtD
Almotriptan—Diarrhoea—Methotrexate—multiple sclerosis	5.4e-05	0.000634	CcSEcCtD
Almotriptan—Dizziness—Methotrexate—multiple sclerosis	5.22e-05	0.000613	CcSEcCtD
Almotriptan—Vomiting—Methotrexate—multiple sclerosis	5.02e-05	0.000589	CcSEcCtD
Almotriptan—Rash—Methotrexate—multiple sclerosis	4.98e-05	0.000585	CcSEcCtD
Almotriptan—Dermatitis—Methotrexate—multiple sclerosis	4.97e-05	0.000584	CcSEcCtD
Almotriptan—Headache—Methotrexate—multiple sclerosis	4.95e-05	0.000581	CcSEcCtD
Almotriptan—Nausea—Methotrexate—multiple sclerosis	4.69e-05	0.000551	CcSEcCtD
Almotriptan—HTR1B—GPCR downstream signaling—CXCL13—multiple sclerosis	3.94e-05	0.00122	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—CCR1—multiple sclerosis	3.94e-05	0.00122	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—GPR65—multiple sclerosis	3.91e-05	0.00121	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.89e-05	0.00121	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.89e-05	0.00121	CbGpPWpGaD
Almotriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	3.88e-05	0.00121	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—LINGO1—multiple sclerosis	3.86e-05	0.0012	CbGpPWpGaD
Almotriptan—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.83e-05	0.00119	CbGpPWpGaD
Almotriptan—HTR1D—G alpha (i) signalling events—POMC—multiple sclerosis	3.81e-05	0.00118	CbGpPWpGaD
Almotriptan—HTR1D—GPCR ligand binding—CXCL10—multiple sclerosis	3.81e-05	0.00118	CbGpPWpGaD
Almotriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	3.8e-05	0.00118	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	3.79e-05	0.00118	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—LINGO1—multiple sclerosis	3.78e-05	0.00117	CbGpPWpGaD
Almotriptan—HTR1B—G alpha (i) signalling events—POMC—multiple sclerosis	3.74e-05	0.00116	CbGpPWpGaD
Almotriptan—HTR1B—GPCR ligand binding—CXCL10—multiple sclerosis	3.73e-05	0.00116	CbGpPWpGaD
Almotriptan—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.68e-05	0.00114	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—CCR1—multiple sclerosis	3.65e-05	0.00113	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—CXCL13—multiple sclerosis	3.65e-05	0.00113	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—CCR1—multiple sclerosis	3.58e-05	0.00111	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—CXCL13—multiple sclerosis	3.58e-05	0.00111	CbGpPWpGaD
Almotriptan—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.52e-05	0.00109	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.47e-05	0.00108	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.47e-05	0.00108	CbGpPWpGaD
Almotriptan—MAOA—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	3.45e-05	0.00107	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	3.38e-05	0.00105	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	3.36e-05	0.00105	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TAGAP—multiple sclerosis	3.35e-05	0.00104	CbGpPWpGaD
Almotriptan—HTR1D—GPCR ligand binding—CCL5—multiple sclerosis	3.28e-05	0.00102	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TAGAP—multiple sclerosis	3.28e-05	0.00102	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—CYP24A1—multiple sclerosis	3.27e-05	0.00101	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—CYP27B1—multiple sclerosis	3.27e-05	0.00101	CbGpPWpGaD
Almotriptan—HTR1B—GPCR ligand binding—CCL5—multiple sclerosis	3.21e-05	0.000998	CbGpPWpGaD
Almotriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	3.03e-05	0.000942	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—GPC5—multiple sclerosis	2.99e-05	0.000928	CbGpPWpGaD
Almotriptan—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.98e-05	0.000927	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—BCHE—multiple sclerosis	2.98e-05	0.000924	CbGpPWpGaD
Almotriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	2.97e-05	0.000922	CbGpPWpGaD
Almotriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	2.97e-05	0.000922	CbGpPWpGaD
Almotriptan—HTR1D—GPCR ligand binding—CCR5—multiple sclerosis	2.96e-05	0.000918	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—S1PR1—multiple sclerosis	2.93e-05	0.000909	CbGpPWpGaD
Almotriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	2.91e-05	0.000903	CbGpPWpGaD
Almotriptan—HTR1B—GPCR ligand binding—CCR5—multiple sclerosis	2.89e-05	0.000899	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—S1PR1—multiple sclerosis	2.87e-05	0.00089	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—GPC5—multiple sclerosis	2.85e-05	0.000884	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—SRM—multiple sclerosis	2.84e-05	0.000884	CbGpPWpGaD
Almotriptan—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	2.84e-05	0.000882	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—GPC5—multiple sclerosis	2.79e-05	0.000866	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—PTGER4—multiple sclerosis	2.76e-05	0.000857	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	2.71e-05	0.00084	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	2.71e-05	0.00084	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—PTGER4—multiple sclerosis	2.7e-05	0.000839	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—CXCR3—multiple sclerosis	2.66e-05	0.000828	CbGpPWpGaD
Almotriptan—CYP2E1—Biological oxidations—POMC—multiple sclerosis	2.64e-05	0.000819	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	2.63e-05	0.000817	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	2.62e-05	0.000815	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—CXCR3—multiple sclerosis	2.61e-05	0.00081	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—CCL3—multiple sclerosis	2.6e-05	0.000808	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—CCR2—multiple sclerosis	2.59e-05	0.000805	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	2.57e-05	0.0008	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—CCL3—multiple sclerosis	2.55e-05	0.000792	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—CCR2—multiple sclerosis	2.54e-05	0.000788	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—PTGER4—multiple sclerosis	2.51e-05	0.000778	CbGpPWpGaD
Almotriptan—MAOA—SIDS Susceptibility Pathways—TNF—multiple sclerosis	2.5e-05	0.000777	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—RGS1—multiple sclerosis	2.49e-05	0.000773	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—RRM1—multiple sclerosis	2.48e-05	0.000769	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—SRM—multiple sclerosis	2.46e-05	0.000764	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—PTGER4—multiple sclerosis	2.45e-05	0.000762	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	2.45e-05	0.000761	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	2.45e-05	0.000761	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—RGS1—multiple sclerosis	2.44e-05	0.000757	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—CXCR3—multiple sclerosis	2.42e-05	0.000752	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—CNR1—multiple sclerosis	2.39e-05	0.000743	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—CXCR3—multiple sclerosis	2.37e-05	0.000736	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—GPR65—multiple sclerosis	2.36e-05	0.000733	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—CCR2—multiple sclerosis	2.35e-05	0.000731	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—CNR1—multiple sclerosis	2.34e-05	0.000727	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—GPR65—multiple sclerosis	2.31e-05	0.000717	CbGpPWpGaD
Almotriptan—HTR1D—GPCR ligand binding—POMC—multiple sclerosis	2.31e-05	0.000717	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—CCR2—multiple sclerosis	2.3e-05	0.000716	CbGpPWpGaD
Almotriptan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.3e-05	0.000715	CbGpPWpGaD
Almotriptan—CYP2C8—Biological oxidations—POMC—multiple sclerosis	2.28e-05	0.000708	CbGpPWpGaD
Almotriptan—HTR1B—GPCR ligand binding—POMC—multiple sclerosis	2.26e-05	0.000702	CbGpPWpGaD
Almotriptan—HTR1D—GPCR ligand binding—CCL2—multiple sclerosis	2.26e-05	0.000702	CbGpPWpGaD
Almotriptan—HTR1B—GPCR ligand binding—CCL2—multiple sclerosis	2.21e-05	0.000687	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—SRM—multiple sclerosis	2.19e-05	0.000682	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—CNR1—multiple sclerosis	2.17e-05	0.000675	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CXCL13—multiple sclerosis	2.16e-05	0.00067	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CCR1—multiple sclerosis	2.16e-05	0.00067	CbGpPWpGaD
Almotriptan—MAOA—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	2.15e-05	0.000669	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—CXCL10—multiple sclerosis	2.15e-05	0.000669	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—CNR1—multiple sclerosis	2.13e-05	0.000661	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CXCL13—multiple sclerosis	2.11e-05	0.000656	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CCR1—multiple sclerosis	2.11e-05	0.000656	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—CXCL10—multiple sclerosis	2.11e-05	0.000655	CbGpPWpGaD
Almotriptan—CYP2C19—Biological oxidations—POMC—multiple sclerosis	2.03e-05	0.000632	CbGpPWpGaD
Almotriptan—MAOA—SIDS Susceptibility Pathways—IL6—multiple sclerosis	2.02e-05	0.000627	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—SRM—multiple sclerosis	2.02e-05	0.000627	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CYP24A1—multiple sclerosis	2e-05	0.000622	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CYP27B1—multiple sclerosis	2e-05	0.000622	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—CXCL10—multiple sclerosis	1.96e-05	0.000607	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—CXCL10—multiple sclerosis	1.91e-05	0.000595	CbGpPWpGaD
Almotriptan—CYP2D6—Biological oxidations—POMC—multiple sclerosis	1.87e-05	0.000581	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—CCL5—multiple sclerosis	1.85e-05	0.000576	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GPC5—multiple sclerosis	1.83e-05	0.000569	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—CCL5—multiple sclerosis	1.82e-05	0.000564	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—APOE—multiple sclerosis	1.79e-05	0.000556	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	1.73e-05	0.000538	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	1.73e-05	0.000538	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—SRM—multiple sclerosis	1.71e-05	0.000531	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.69e-05	0.000526	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—CCL5—multiple sclerosis	1.68e-05	0.000523	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—CCR5—multiple sclerosis	1.67e-05	0.000519	CbGpPWpGaD
Almotriptan—MAOA—Neuronal System—MAPK1—multiple sclerosis	1.65e-05	0.000513	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—CCL5—multiple sclerosis	1.65e-05	0.000512	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—IL2RA—multiple sclerosis	1.65e-05	0.000511	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—CCR5—multiple sclerosis	1.64e-05	0.000508	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—IL2RA—multiple sclerosis	1.61e-05	0.000501	CbGpPWpGaD
Almotriptan—CYP1A2—Biological oxidations—POMC—multiple sclerosis	1.58e-05	0.000492	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GPC5—multiple sclerosis	1.58e-05	0.000492	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	1.55e-05	0.00048	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	1.55e-05	0.00048	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—POMC—multiple sclerosis	1.54e-05	0.000478	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CCL3—multiple sclerosis	1.54e-05	0.000478	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—RRM1—multiple sclerosis	1.52e-05	0.000472	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—CCR5—multiple sclerosis	1.52e-05	0.000471	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.51e-05	0.000469	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CCL3—multiple sclerosis	1.51e-05	0.000468	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—IL2RA—multiple sclerosis	1.49e-05	0.000464	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—CCR5—multiple sclerosis	1.49e-05	0.000461	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PTGER4—multiple sclerosis	1.48e-05	0.00046	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—IL2RA—multiple sclerosis	1.46e-05	0.000455	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PGR—multiple sclerosis	1.46e-05	0.000453	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PTGER4—multiple sclerosis	1.45e-05	0.00045	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CXCR3—multiple sclerosis	1.43e-05	0.000444	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PGR—multiple sclerosis	1.43e-05	0.000443	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	1.42e-05	0.000442	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	1.42e-05	0.000442	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—BCHE—multiple sclerosis	1.42e-05	0.000442	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CD28—multiple sclerosis	1.42e-05	0.00044	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GPC5—multiple sclerosis	1.41e-05	0.000439	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—ALB—multiple sclerosis	1.4e-05	0.000435	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CXCR3—multiple sclerosis	1.4e-05	0.000435	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CCR2—multiple sclerosis	1.39e-05	0.000432	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CD28—multiple sclerosis	1.39e-05	0.000431	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CCR2—multiple sclerosis	1.36e-05	0.000423	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—SRM—multiple sclerosis	1.32e-05	0.00041	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—RRM1—multiple sclerosis	1.31e-05	0.000408	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—POMC—multiple sclerosis	1.31e-05	0.000405	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GPC5—multiple sclerosis	1.3e-05	0.000404	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CNR1—multiple sclerosis	1.28e-05	0.000399	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—POMC—multiple sclerosis	1.28e-05	0.000397	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CNR1—multiple sclerosis	1.26e-05	0.00039	CbGpPWpGaD
Almotriptan—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.22e-05	0.00038	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	1.2e-05	0.000374	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	1.2e-05	0.000374	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—POMC—multiple sclerosis	1.19e-05	0.000368	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.18e-05	0.000366	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—RRM1—multiple sclerosis	1.17e-05	0.000364	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—POMC—multiple sclerosis	1.16e-05	0.000361	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—CCL2—multiple sclerosis	1.16e-05	0.00036	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CXCL10—multiple sclerosis	1.16e-05	0.000359	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—CCL2—multiple sclerosis	1.14e-05	0.000353	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CXCL10—multiple sclerosis	1.13e-05	0.000351	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GPC5—multiple sclerosis	1.1e-05	0.000342	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—RRM1—multiple sclerosis	1.08e-05	0.000335	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—TYK2—multiple sclerosis	1.05e-05	0.000327	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—TYK2—multiple sclerosis	1.03e-05	0.00032	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.02e-05	0.000316	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CD86—multiple sclerosis	1.01e-05	0.000314	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CCL5—multiple sclerosis	9.94e-06	0.000309	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CD86—multiple sclerosis	9.89e-06	0.000307	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CCL5—multiple sclerosis	9.74e-06	0.000302	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—IL2—multiple sclerosis	9.65e-06	0.0003	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—IL2—multiple sclerosis	9.45e-06	0.000293	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	9.3e-06	0.000289	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	9.3e-06	0.000289	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—SPP1—multiple sclerosis	9.21e-06	0.000286	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—RRM1—multiple sclerosis	9.13e-06	0.000284	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	9.09e-06	0.000282	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—SPP1—multiple sclerosis	9.02e-06	0.00028	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CCR5—multiple sclerosis	8.96e-06	0.000278	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IL2RA—multiple sclerosis	8.83e-06	0.000274	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CCR5—multiple sclerosis	8.77e-06	0.000272	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—IL2—multiple sclerosis	8.76e-06	0.000272	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	8.75e-06	0.000272	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—BCHE—multiple sclerosis	8.72e-06	0.000271	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IL2RA—multiple sclerosis	8.65e-06	0.000269	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—IL2—multiple sclerosis	8.58e-06	0.000267	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—APOE—multiple sclerosis	8.55e-06	0.000266	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GPC5—multiple sclerosis	8.5e-06	0.000264	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—APOE—multiple sclerosis	8.15e-06	0.000253	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—APOE—multiple sclerosis	7.98e-06	0.000248	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	7.98e-06	0.000248	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.81e-06	0.000243	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—BCHE—multiple sclerosis	7.54e-06	0.000234	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CD80—multiple sclerosis	7.37e-06	0.000229	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—POMC—multiple sclerosis	7.35e-06	0.000228	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CD80—multiple sclerosis	7.22e-06	0.000224	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	7.12e-06	0.000221	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7.08e-06	0.00022	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—RRM1—multiple sclerosis	7.05e-06	0.000219	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—POMC—multiple sclerosis	7e-06	0.000217	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—POMC—multiple sclerosis	6.86e-06	0.000213	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CCL2—multiple sclerosis	6.85e-06	0.000213	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—BCHE—multiple sclerosis	6.73e-06	0.000209	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CCL2—multiple sclerosis	6.71e-06	0.000208	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—MAPK1—multiple sclerosis	6.7e-06	0.000208	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—ALB—multiple sclerosis	6.7e-06	0.000208	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—MAPK1—multiple sclerosis	6.56e-06	0.000204	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TYK2—multiple sclerosis	6.22e-06	0.000193	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—BCHE—multiple sclerosis	6.19e-06	0.000192	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TYK2—multiple sclerosis	6.09e-06	0.000189	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.09e-06	0.000189	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.55e-06	0.000172	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—APOE—multiple sclerosis	5.25e-06	0.000163	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—BCHE—multiple sclerosis	5.24e-06	0.000163	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IL2—multiple sclerosis	5.18e-06	0.000161	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—IL6—multiple sclerosis	5.15e-06	0.00016	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IL2—multiple sclerosis	5.07e-06	0.000157	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—IL6—multiple sclerosis	5.04e-06	0.000157	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MMP9—multiple sclerosis	4.9e-06	0.000152	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MMP9—multiple sclerosis	4.8e-06	0.000149	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—APOE—multiple sclerosis	4.54e-06	0.000141	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—POMC—multiple sclerosis	4.51e-06	0.00014	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—STAT3—multiple sclerosis	4.36e-06	0.000135	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—STAT3—multiple sclerosis	4.27e-06	0.000132	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ALB—multiple sclerosis	4.11e-06	0.000128	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—APOE—multiple sclerosis	4.05e-06	0.000126	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MYC—multiple sclerosis	4.05e-06	0.000126	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—BCHE—multiple sclerosis	4.05e-06	0.000126	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TGFB1—multiple sclerosis	4.04e-06	0.000125	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MYC—multiple sclerosis	3.96e-06	0.000123	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MAPK1—multiple sclerosis	3.96e-06	0.000123	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TGFB1—multiple sclerosis	3.95e-06	0.000123	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—POMC—multiple sclerosis	3.9e-06	0.000121	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MAPK1—multiple sclerosis	3.88e-06	0.00012	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—APOE—multiple sclerosis	3.72e-06	0.000116	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ALB—multiple sclerosis	3.55e-06	0.00011	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—POMC—multiple sclerosis	3.48e-06	0.000108	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—POMC—multiple sclerosis	3.2e-06	9.94e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ALB—multiple sclerosis	3.17e-06	9.85e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—APOE—multiple sclerosis	3.15e-06	9.8e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IL6—multiple sclerosis	3.04e-06	9.45e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IL6—multiple sclerosis	2.98e-06	9.25e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ALB—multiple sclerosis	2.92e-06	9.06e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—POMC—multiple sclerosis	2.71e-06	8.42e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ALB—multiple sclerosis	2.47e-06	7.67e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—APOE—multiple sclerosis	2.43e-06	7.56e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—POMC—multiple sclerosis	2.09e-06	6.5e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ALB—multiple sclerosis	1.91e-06	5.92e-05	CbGpPWpGaD
